GTP Bioways attends I4ID 2024 in Lyon
We are pleased to announce that GTP Bioways will be attending the I4ID Congress 2024, held on November 27-28, 2024, in Lyon, France. This highly anticipated event brings together experts and innovators from the immunotherapy and infectious disease fields, offering a unique platform to explore the latest scientific and technological breakthroughs.
As a CDMO (Contract Development and Manufacturing Organization) specializing in process development for biologics and GMP manufacturing, GTP Bioways is committed to supporting the development of novel therapies, including antibody-drug conjugates (ADCs), monoclonal antibodies, and other biologics aimed at combating infectious diseases and advancing immunotherapy solutions.
The I4ID Congress provides an excellent opportunity for us to engage with key stakeholders from the biotechnology, pharmaceutical, and academic sectors. We look forward to discussing how our integrated services, from cell line development to clinical-stage manufacturing, can help accelerate your therapeutic programs.
Our team of experts will be available throughout the event to discuss how GTP Bioways can support your projects, from early-stage development to clinical trials. Whether you are working on cutting-edge immunotherapy treatments or combating infectious diseases, we are here to provide the expertise and services you need to succeed.
If you are attending the I4ID Congress 2024 and would like to schedule a meeting with us, please reach us via our online form on our website.
We look forward to connecting with you in Lyon and exploring how we can contribute to advancing your innovations.
